Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SGLT2i Therapy in Islet Transplantation (SIT)

NCT07228195 is registered in ClinicalTrials.gov with University of Minnesota as lead sponsor.

NCT NCT07228195
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07228195 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SGLT2i Therapy in Islet Transplantation (SIT)
Lead sponsor
University of Minnesota
Phase
Phase 4
Overall status
Recruiting
Start date
July 21, 2026
Completion date
December 1, 2028
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes, partial islet function, tpiat